News
-
-
PRESS RELEASE
EMBARC Announces Its Intention to Collaborate with Insmed on Landmark Interventional Study Evaluating Disease Modification Potential of Brensocatib in Bronchiectasis
EMBARC announces collaboration with Insmed on landmark interventional study evaluating disease modification potential of brensocatib in bronchiectasis. Study aims to enroll 3,000 patients across Europe